alexa
Reach Us +1-947-333-4405

GET THE APP

Mohammad Usman Shaikh | OMICS International
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 1174

Journal of Clinical & Experimental Pathology received 1174 citations as per Google Scholar report

Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Mohammad Usman Shaikh

Department of Pathology and Microbiology, Section of Hematology, The Aga Khan University Hospital, Karachi, Pakistan

Biography

Mohammad Usman Shaikh is currently working as a Professor in the Department of Pathology,and Microbiology, Section of Hematology, The Aga Khan University Hospital, Karachi, Pakistan . The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology
Publications

Response to Imatinib Mesylate in Patients with Early Chronic Phase Chronic Myeloid Leukemia and Derivative Chromosome 9 Deletion or Clonal Evolution

Objectives: The significance of clonal evolution and derivative chromosome 9 in Philadelphia-positive CML is not fully characterized and studies have yielded conflicting results. After working on emergence of clonal evolution from our region, we continued to find out the response of Imatinib Mesylate on such cases of CML treated in our center. Ma... Read More»

Mohammad Usman Shaikh, Tariq Moatter, Naveen Naz Syed, Natasha Ali and Salman Naseem Adil

Research Article: J Clin Exp Pathol 2014, 4: 166

DOI: 10.4172/2161-0681.1000166

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top